Line 5 Tablet contains Levocetirizine 5mg, a second-generation antihistamine indicated for the relief of symptoms associated with allergic conditions such as allergic rhinitis and chronic idiopathic urticaria. Levocetirizine selectively inhibits peripheral H1 histamine receptors, thereby reducing the effects of histamine, a key mediator in allergic responses. This action alleviates symptoms including sneezing, nasal congestion, rhinorrhea, itchy or watery eyes, and urticarial wheals and pruritus. The tablet formulation ensures convenient oral administration with rapid absorption and onset of action, typically within one hour, providing sustained relief for up to 24 hours. Levocetirizine is well tolerated with a low incidence of sedation compared to first-generation antihistamines, making it suitable for daytime use. It is recommended to be taken once daily, with or without food. Caution is advised in patients with renal impairment, and dosage adjustments may be necessary. Line 5 Tablet should be used under medical supervision, particularly in pregnant or lactating women, and in individuals with known hypersensitivity to levocetirizine or related compounds. Adverse effects are generally mild and transient, including headache, dry mouth, and fatigue. This medication offers effective symptomatic management of allergic disorders, improving patient quality of life.